CDK4 and glioblastoma: To further seek the role and mechanism of PD-L1 in the occurrence and development of glioblastoma, we found that knocking down PD-L1 in glioblastoma cells inhibited CDK4, CDK6, MMP-2, and vimentin molecular proteins, and decreased the proliferation and migration ability of glioblastoma cells.